Skip to search.
 TSX Up 0.26% TSX Ventures Up 0.38%

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS
51.01 Up 2.26(4.64%) 2:58PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:48.75
Open:49.05
Bid:51.00 x 300
Ask:51.09 x 100
1y Target Est:65.00
Beta:2.22577
Earnings Date:Nov 5 - Nov 9 (Est.)
Day's Range:48.65 - 51.33
52wk Range:35.26 - 77.80
Volume:1,163,999
Avg Vol (3m):2,210,870
Market Cap:6.12B
P/E (ttm):268.47
EPS (ttm):0.19
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ISISUp 4.64%6.12B
GILDUp 1.30%150.88B
ENZUp 0.69%134.03M
SRPTUp 2.56%1.50B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):18.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.52
Quarterly EPS Est (Sep-15) :-0.31
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-4.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback